不稳定软骨病灶在半月板部分切除术中观察与清创的患者结局:软骨病灶与半月板手术(ChAMP)随机对照试验
研究纳入年龄≥30岁接受关节镜下半月板部分切除术的患者,随机分为对不稳定Outerbridge II、III或IV级软骨病灶进行清创(CL-Deb组,n=98)或观察(CL-noDeb组,n=92)。术后1年两组各项结局评分无显著差异,作者认为对术中遇到的不稳定软骨病灶行关节镜清创无获益,推荐将这些病灶留在原位。
要点
- 术后1年两组WOMAC疼痛评分等所有结局评分均无显著差异。
- CL-noDeb组在术后8至12天、6周、3个月、6个月部分指标优于CL-Deb组。
- 作者认为对半月板部分切除术中遇到的不稳定软骨病灶行关节镜清创无获益,推荐留在原位。
核心结论
- CL-Deb组与CL-noDeb组术后1年结局无差异,提示对半月板部分切除术中遇到的不稳定软骨病灶行关节镜清创无获益,推荐将这些病灶留在原位。
研究设计与样本
- 随机对照试验,纳入年龄≥30岁接受关节镜下半月板部分切除术的患者,随机分为清创组(CL-Deb组,n=98)与观察组(CL-noDeb组,n=92),针对不稳定Outerbridge II、III或IV级软骨病灶。
- 结局在术前及术后8至12天、6周、3个月、6个月、1年评估,主要结局为术后1年WOMAC疼痛评分,采用t检验比较组间差异,报告均数与标准差。
主要发现
- 术后1年两组所有结局评分均无显著差异。
- 与CL-Deb组相比,CL-noDeb组术后8至12天KOOS生活质量评分改善(p=0.04)、SF-36生理功能评分改善(p=0.01)、股四头肌周径增加(p=0.02)。
- 与CL-Deb组相比,CL-noDeb组术后6周WOMAC疼痛评分改善(p=0.02)、KOOS疼痛评分改善(p=0.04)。
- 与CL-Deb组相比,CL-noDeb组术后3个月SF-36生理功能评分改善(p=0.01)。
- 与CL-Deb组相比,CL-noDeb组术后6个月股四头肌周径增加(p=0.02)。
关键数值与推荐
- 证据等级:治疗性I级。
临床怎么用
- 作者认为对关节镜下半月板部分切除术中遇到的不稳定软骨病灶行关节镜清创无获益,推荐将这些病灶留在原位。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is unknown whether unstable chondral lesions observed during arthroscopic partial meniscectomy (APM) require treatment. We examined differences at 1 year with respect to knee pain and other outcomes between patients who had debridement (CL-Deb) and those who had observation (CL-noDeb) of unstable chondral lesions encountered during APM. METHODS: Patients who were ≥30 years old and undergoing APM were randomized to receive debridement (CL-Deb group; n = 98) or observation (CL-noDeb; n = 92) of unstable Outerbridge grade-II, III, or IV chondral lesions. Outcomes were evaluated preoperatively and at 8 to 12 days, 6 weeks, 3 months, 6 months, and 1 year postoperatively. Outcome measures included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Knee Injury and Osteoarthritis Outcome Score (KOOS), visual analog scale (VAS) pain score, Short Form-36 (SF-36) health survey, range of motion, quadriceps circumference, and effusion. The primary outcome was the WOMAC pain score at 1 year. T tests were used to examine group differences in outcomes, and the means and standard deviations are reported. RESULTS: There were no significant differences between the groups with respect to any of the 1-year outcome scores. Compared with the CL-Deb group, the CL-noDeb group had improvement in the KOOS quality-of-life (p = 0.04) and SF-36 physical functioning scores (p = 0.01) as well as increased quadriceps circumference at 8 to 12 days (p = 0.02); had improvement in the pain score on the WOMAC (p = 0.02) and KOOS (p = 0.04) at 6 weeks; had improvement in SF-36 physical functioning scores at 3 months (p = 0.01); and had increased quadriceps circumference at 6 months (p = 0.02). CONCLUSIONS: Outcomes for the CL-Deb and CL-noDeb groups did not differ at 1 year postoperatively. This suggests that there is no benefit to arthroscopic debridement of unstable chondral lesions encountered during APM, and it is recommended that these lesions be left in situ. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
引用
- Bisson LJ, Kluczynski MA, Wind WM, et al. Patient Outcomes After Observation Versus Debridement of Unstable Chondral Lesions During Partial Meniscectomy: The Chondral Lesions And Meniscus Procedures (ChAMP) Randomized Controlled Trial. J Bone Joint Surg Am. 2017. PMID: 28678120. doi:10.2106/JBJS.16.00855
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。